Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design,
Administration, Oral
Animals
Biological Availability
Catechols
/ administration & dosage
Chemistry, Pharmaceutical
/ methods
Drug Delivery Systems
/ methods
Emulsions
/ administration & dosage
Hyperuricemia
/ drug therapy
Male
Mice
Particle Size
Polyethylene Glycols
/ chemistry
Rats
Rats, Sprague-Dawley
Solubility
/ drug effects
Surface-Active Agents
/ chemistry
6-shogaol
Self-micro emulsifying drug delivery system
central composite design - response surface methodology
hyperuricemia
oral bioavailability
Journal
Drug development and industrial pharmacy
ISSN: 1520-5762
Titre abrégé: Drug Dev Ind Pharm
Pays: England
ID NLM: 7802620
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
pubmed:
17
4
2019
medline:
18
12
2019
entrez:
17
4
2019
Statut:
ppublish
Résumé
The prevalence of hyperuricemia is relatively high worldwide, and a great number of patients are suffering from its complications. 6-shogaol, an alkylphenol compound purified from the root of ginger (
Identifiants
pubmed: 30990749
doi: 10.1080/03639045.2019.1594885
doi:
Substances chimiques
Catechols
0
Emulsions
0
Surface-Active Agents
0
Polyethylene Glycols
3WJQ0SDW1A
shogaol
83DNB5FIRF
polyethylene glycol 400
B697894SGQ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM